Get in touch to make an enquiry about The North West
Visit our business support page for useful links to other local,
regional and national support organisations.
The company supplies precision containment valves to some of the
biggest pharmaceutical names across the globe.
The decision to relocate to larger premises in Speke, was made
to help the company expand and compete more effectively in the
growing aseptic bio-pharma market.
ChargePoint is currently the second largest
manufacturer in the world for containment valves and is
investing heavily in product development to become the major player
for the technology, which is used for transferring raw materials
safely and efficiently.
ChargePoint's new headquarters are a 27,000 sq ft production and
office space and have been fitted out with more than £1 million
worth of technology for the manufacture of the devices that are
transforming the way medicines and vaccines are processed.
Managing Director, Chris Eccles said, "Our move is in line with
our growth and our ambition and drive to offer the highest quality
products for sectors that need to use contained transfers.
"We have invested in state-of-the art technology to improve our
unique and progressive devices and this commitment will be evident
in the technology in development at present.
"The first quarter of 2016 showed phenomenal growth for the
company and we have adapted to the demand around the world for our
The company received a £900,000 investment from The North West
Fund in 2013 and has used the finance to create more than 65
skilled jobs, as well as expand into new markets.
ChargePoint exports approximately 80% of its products and won
the Queen's Award for International Trade in 2012. In 2015, global
sales saw a 20% increase on 2014 at just over £8 million.
ChargePoint generates 20% of its annual revenues in the US and
its customers include pharma heavyweights such as Merck, Roche
Genentech, Johnson & Johnson, Ritedose and Pfizer. It is also
seeing rapid growth in countries such as China and India.
Originally developed in 1996 in conjunction with
GlaxoSmithKline, ChargePoint valves are now used by almost every
major pharmaceutical manufacturer globally and increasingly in
other industries such as chemical, food manufacture and consumer